Graham Capital Management »

Design Therapeutics shares owned by Graham Capital Management

Quarter-by-quarter ownership of Design Therapeutics (DSGN) shares owned by Graham Capital Management from 13F filings

Historical chart of Graham Capital Management investment in Design Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Design Therapeutics held by Graham Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Design Therapeutics by Graham Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $60k 23k 2.65
2023-09-30 $52k 22k 2.36

More positions owned by Graham Capital Management

Ishares Tr Russell 2000 Etf (IWM)
Microstrategy Cl A New Put Option (MSTR)
Zillow Group Note 0.750% 9/0 (Principal)
Microstrategy Note 0.750%12/1 (Principal)
Permian Resources Corp Note 3.250% 4/0 (Principal)
Peabody Engr Corp Note 3.250% 3/0 (Principal)
Tilray Brands Note 5.200% 6/1 (Principal)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Transocean Deb 4.000%12/1 (Principal)
Bill Holdings Note 12/0 (Principal)
Opko Health Note 4.500% 2/1 (Principal)
Bloom Energy Corp Note 2.500% 8/1 (Principal)
Maxeon Solar Technologies Lt SHS Call Option (MAXN)
Maxeon Solar Technologies Lt Note 6.500% 7/1 (Principal)
Zscaler Note 0.125% 7/0 (Principal)

View all positions for Graham Capital Management

Top funds holding Design Therapeutics

Sr One Capital Management
Logos Global Management
Citadel Advisors
Baker Bros. Advisors
Tang Capital Management
Almitas Capital
Goldman Sachs Group
Vanguard Group
BML Capital Management
Two Sigma Advisers
Jacobs Levy Equity Management
Two Sigma Investments
Millennium Management
Walleye Trading Advisors
Assenagon Asset Management

View all funds holding Design Therapeutics